{"id":29088,"date":"2012-05-05T12:51:17","date_gmt":"2012-05-05T16:51:17","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=29088"},"modified":"2012-05-05T12:51:17","modified_gmt":"2012-05-05T16:51:17","slug":"hologic-acquires-gen-probe-for-82-75-per-share","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/05\/05\/hologic-acquires-gen-probe-for-82-75-per-share\/","title":{"rendered":"Hologic Acquires Gen-Probe For $82.75 Per Share"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v92c10a171136eeb07d0b5bf3ca345010aaee320a&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v92c10a171136eeb07d0b5bf3ca345010aaee320a&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Hologic (NASDAQ:HOLX) announced its acquisition of Gen-Probe (NASDAQ:GPRO) in a cash deal valued at $82.75 a share, which represents a 20% premium over the company&#8217;s Friday close.The company expects the deal to add $0.20 per share to adjusted EPS in its first year after the closing of the deal.Hologic expects to fund the deal through cash, and added term loans.<\/p>\n<p><img src='http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/05\/05\/1_dqpifiv5_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/05\/05\/1_dqpifiv5_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hologic (NASDAQ:HOLX) announced its acquisition of Gen-Probe (NASDAQ:GPRO) in a cash deal valued at $82.75 a share, which represents a 20% premium over the company&#8217;s Friday close.The company expects the deal to add $0.20 per share to adjusted EPS in its first year after the closing of the deal.Hologic expects to fund the deal through &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2012\/05\/05\/hologic-acquires-gen-probe-for-82-75-per-share\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hologic Acquires Gen-Probe For $82.75 Per Share&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-29088","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/29088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=29088"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/29088\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=29088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=29088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=29088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}